These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Reversal of mouse hepatic failure using an implanted liver-assist device containing ES cell-derived hepatocytes. Soto-Gutiérrez A; Kobayashi N; Rivas-Carrillo JD; Navarro-Alvarez N; Zhao D; Okitsu T; Noguchi H; Basma H; Tabata Y; Chen Y; Tanaka K; Narushima M; Miki A; Ueda T; Jun HS; Yoon JW; Lebkowski J; Tanaka N; Fox IJ Nat Biotechnol; 2006 Nov; 24(11):1412-9. PubMed ID: 17086173 [TBL] [Abstract][Full Text] [Related]
45. Assessment of the AMC-bioartificial liver in the anhepatic pig. Sosef MN; Abrahamse LS; van de Kerkhove MP; Hartman R; Chamuleau RA; van Gulik TM Transplantation; 2002 Jan; 73(2):204-9. PubMed ID: 11821731 [TBL] [Abstract][Full Text] [Related]
46. Artificial liver support in pigs with acetaminophen-induced acute liver failure. He GL; Feng L; Cai L; Zhou CJ; Cheng Y; Jiang ZS; Pan MX; Gao Y World J Gastroenterol; 2017 May; 23(18):3262-3268. PubMed ID: 28566885 [TBL] [Abstract][Full Text] [Related]
51. Artificial liver support as a bridge to orthotopic liver transplantation in a case of acute liver dysfunction on non-alcoholic steatohepatitis (NASH). Gaspari R; Pennisi MA; Mignani V; Gasbarrini A; Mercurio G; Di Campli C; Conti G; Gentiloni Silveri N; Proietti R Z Gastroenterol; 2001 Jun; 39 Suppl 2():15-7. PubMed ID: 16215887 [No Abstract] [Full Text] [Related]
52. [New devices in liver replacement therapy]. Rifai K; Bahr MJ; Schneider A; Ott M; Manns MP Med Klin (Munich); 2003 Dec; 98(12):750-3. PubMed ID: 14685676 [TBL] [Abstract][Full Text] [Related]
53. Acute liver failure: liver support therapies. Stadlbauer V; Jalan R Curr Opin Crit Care; 2007 Apr; 13(2):215-21. PubMed ID: 17327745 [TBL] [Abstract][Full Text] [Related]
54. Usefulness of corticosteroids for the treatment of severe and fulminant forms of autoimmune hepatitis. Ichai P; Duclos-Vallée JC; Guettier C; Hamida SB; Antonini T; Delvart V; Saliba F; Azoulay D; Castaing D; Samuel D Liver Transpl; 2007 Jul; 13(7):996-1003. PubMed ID: 17370335 [TBL] [Abstract][Full Text] [Related]
55. Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience. Tillmann HL; Hadem J; Leifeld L; Zachou K; Canbay A; Eisenbach C; Graziadei I; Encke J; Schmidt H; Vogel W; Schneider A; Spengler U; Gerken G; Dalekos GN; Wedemeyer H; Manns MP J Viral Hepat; 2006 Apr; 13(4):256-63. PubMed ID: 16611192 [TBL] [Abstract][Full Text] [Related]
56. Presence of intrahepatic (total and ccc) HBV DNA is not predictive of HBV recurrence after liver transplantation. Hussain M; Soldevila-Pico C; Emre S; Luketic V; Lok AS; Liver Transpl; 2007 Aug; 13(8):1137-44. PubMed ID: 17663390 [TBL] [Abstract][Full Text] [Related]
57. Cell-based therapy for liver diseases. Di Campli C; Nestola M; Piscaglia AC; Santoliquido A; Gasbarrini G; Pola P; Gasbarrini A Eur Rev Med Pharmacol Sci; 2003; 7(2):41-4. PubMed ID: 12911118 [TBL] [Abstract][Full Text] [Related]
58. Clinical experience with a porcine hepatocyte-based liver support system. Chen SC; Hewitt WR; Watanabe FD; Eguchi S; Kahaku E; Middleton Y; Rozga J; Demetriou AA Int J Artif Organs; 1996 Nov; 19(11):664-9. PubMed ID: 8970834 [TBL] [Abstract][Full Text] [Related]
59. Artificial liver support system reduces intracranial pressure more effectively than bioartificial system: an experimental study. Ryska O; Pantoflicek T; Laszikova E; Prazak J; Koblihova E; Ryska M Int J Artif Organs; 2012 Jul; 35(7):503-10. PubMed ID: 22476878 [TBL] [Abstract][Full Text] [Related]
60. Improved survival of porcine acute liver failure by a bioartificial liver device implanted with induced human functional hepatocytes. Shi XL; Gao Y; Yan Y; Ma H; Sun L; Huang P; Ni X; Zhang L; Zhao X; Ren H; Hu D; Zhou Y; Tian F; Ji Y; Cheng X; Pan G; Ding YT; Hui L Cell Res; 2016 Feb; 26(2):206-16. PubMed ID: 26768767 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]